![Amy Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Levin
Chief Tech/Sci/R&D Officer at
ONCOLYTICS BIOTECH INC.
Net worth: 32 056 $ as of 2026-08-30
Profile
Amy Levin currently works at Oncolytics Biotech, Inc., as Vice President-Clinical Operations from 2020.
Ms. Levin also formerly worked at Puma Biotechnology, Inc., as Senior Director-Clinical Operations from 2011 to 2020 and Janssen Oncology, Inc., as Director-Clinical Program Leader from 2007 to 2011.
Ms. Levin received her undergraduate degree from The University of Texas at Austin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-09 | 38,253 ( 0.03% ) | 32 056 $ | 2026-08-30 |
Amy Levin active positions
| Companies | Position | Start |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Chief Tech/Sci/R&D Officer | 2020-08-31 |
Former positions of Amy Levin
| Companies | Position | End |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Corporate Officer/Principal | 2011-11-30 |
Training of Amy Levin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Amy Levin
